β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway

Marie Vidal1, Thomas Wieland, Martin J Lohse

  • 1Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Strasse 9, 97078 Würzburg, Germany.

Abstract

Insights

Beta-adrenergic receptor activation induces cardiac hypertrophy through a novel pathway involving G protein G(s) and extracellular signal-regulated kinases (Erk). This Erk(Thr188) phosphorylation is critical for hypertrophic remodeling and may offer new therapeutic targets.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Signaling

Background:

  • Beta-1 adrenergic receptor and G(s) protein activation induce cardiac hypertrophy.
  • Canonical G(s) effectors (adenylyl cyclase and protein kinase A) are insufficient for hypertrophy.
  • G(q) protein βγ subunits induce cardiac hypertrophy via extracellular signal-regulated kinases (Erk1/2) phosphorylation at threonine188.

Purpose of the Study:

  • Investigate if β-adrenergic receptors induce cardiac hypertrophy via Erk(Thr188) phosphorylation.
  • Elucidate the signaling pathway linking β-adrenergic receptors to Erk(Thr188) phosphorylation and cardiac hypertrophy.

Main Methods:

  • Utilized mouse hearts and neonatal cardiomyocytes.
  • Employed Erk1/2 inhibition and Erk2(T188A/T188S) phosphorylation-deficient mutants.
  • Administered isoproterenol and forskolin (adenylyl cyclase activator).
  • Assessed Erk(Thr188) phosphorylation, nuclear Erk accumulation, and cardiomyocyte hypertrophy.
  • Investigated the role of Gβγ subunits.
  • Conducted long-term in vivo studies with Erk2(T188S) transgenic mice.

Main Results:

  • β-Adrenergic receptor activation induced Erk(Thr188) phosphorylation in cardiac cells and mouse hearts.
  • Erk1/2 inhibition or Erk2(T188A/T188S) mutants attenuated β-adrenergic cardiomyocyte hypertrophy.
  • Isoproterenol, but not forskolin, induced Erk(Thr188) phosphorylation and nuclear Erk accumulation.
  • Erk(Thr188) phosphorylation required Gβγ released from G(s).
  • Long-term isoproterenol treatment caused cardiac hypertrophy and remodeling in mice, which was reduced in Erk2(T188S) mice.

Conclusions:

  • β-Adrenergic receptor activation of G(s) triggers both canonical Erk1/2 activation via adenylyl cyclase and Gβγ release.
  • Released Gβγ associates with Erk1/2, inducing Erk(Thr188) phosphorylation, nuclear translocation, and cardiomyocyte hypertrophy.
  • This pathway is critical for β-adrenergically mediated cardiac hypertrophy and presents potential therapeutic targets for hypertrophic remodeling.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...